Prosecution Insights
Last updated: November 04, 2026
Application No. 17/773,652

AN IMPLANTABLE DEVICE FOR REPAIRING A CARDIAC VALVE

Non-Final OA §102§103§112
Filed
May 02, 2022
Priority
Nov 05, 2019 — provisional 62/930,599 +2 more
Examiner
BARIA, DINAH N
Art Unit
3774
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Tau Cardio Inc.
OA Round
3 (Non-Final)
73%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allowance Rate
479 granted / 656 resolved
+3.0% vs TC avg
Strong +28% interview lift
Without
With
+28.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
47 currently pending
Career history
713
Total Applications
across all art units

Statute-Specific Performance

§101
1.9%
-38.1% vs TC avg
§103
38.8%
-1.2% vs TC avg
§102
16.8%
-23.2% vs TC avg
§112
32.8%
-7.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 656 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 03/17/2026 has been entered. Status of Claims This office action is responsive to the amendment filed on 03/17/2026. As directed by the amendment: claims 1-13 have been cancelled and new claims 14-25 have been added. Newly submitted claims 21-25 are directed to an invention that is independent or distinct from the invention originally claimed for the following reasons: the original invention, as set forth in claims 14-20, is directed towards an implantable device, while the invention of claims 21-25 is directed towards a method of treating a regurgitation of blood flow through a diseased cardiac valve. The inventions are related as product and process of use; the inventions can be shown to be distinct if either or both of the following can be shown: (1) the process for using the product as claimed can be practiced with another materially different product or (2) the product as claimed can be used in a materially different process of using that product. See MPEP § 806.05(h). In the instant case the product as claimed can be used in a materially different process as being placed in a venous valve and/or implanted such that the central member is perpendicular to a valve annulus, not extending obliquely. Since applicant has received an action on the merits for the originally presented invention, this invention has been constructively elected by original presentation for prosecution on the merits. Accordingly, claims 21-25 are withdrawn from consideration as being directed to a non-elected invention. See 37 CFR 1.142(b) and MPEP § 821.03. To preserve a right to petition, the reply to this action must distinctly and specifically point out supposed errors in the restriction requirement. Otherwise, the election shall be treated as a final election without traverse. Traversal must be timely. Failure to timely traverse the requirement will result in the loss of right to petition under 37 CFR 1.144. If claims are subsequently added, applicant must indicate which of the subsequently added claims are readable upon the elected invention. Should applicant traverse on the ground that the inventions are not patentably distinct, applicant should submit evidence or identify such evidence now of record showing the inventions to be obvious variants or clearly admit on the record that this is the case. In either instance, if the examiner finds one of the inventions unpatentable over the prior art, the evidence or admission may be used in a rejection under 35 U.S.C. 103 or pre-AIA 35 U.S.C. 103(a) of the other invention. Drawings The drawings are objected to under 37 CFR 1.83(a). The drawings must show every feature of the invention specified in the claims. Therefore, the implantable device comprising an annular member, a central member, and at least one connection member fixedly supporting the central member from the annular member such that the entirety of a distal portion of the central member is permanently spaced apart from the annular member, and wherein the central member being configured with a curved shape to facilitate leaflet coaptation (claim 17), and the implantable device comprising an annular member, a central member, and at least one connection member fixedly supporting the central member from the annular member such that the entirety of a distal portion of the central member is permanently spaced apart from the annular member, and wherein the central member has a croissant shape (claim 18) must be shown or the feature(s) canceled from the claim(s). No new matter should be entered. Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. The figure or figure number of an amended drawing should not be labeled as “amended.” If a drawing figure is to be canceled, the appropriate figure must be removed from the replacement sheet, and where necessary, the remaining figures must be renumbered and appropriate changes made to the brief description of the several views of the drawings for consistency. Additional replacement sheets may be necessary to show the renumbering of the remaining figures. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 14-20 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. Claim 14 sets forth the parameters of “at least one connection member fixedly supporting the central member” (emphasis added), on line 6, “the central member is permanently spaced apart from the annular member” (emphasis added), on the 2nd to last line, and the central member “is not pivotally mounted relative to the annular member” (emphasis added), on the last line of the claim; however, none of these parameters were ever mentioned in the originally filed disclosure. Specifically, the originally filed specification never specifically mentions that the at least one connection member “fixedly” supports the central member, nor is it ever mentioned that the central member is “permanently” spaced apart from the annular member, or that the central member is “not pivotally” mounted relative to the annular member. The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 14-20 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 14 sets forth the parameters of “the central member is permanently spaced apart from the annular member” (emphasis added), on the 2nd to last line and the central member “is not pivotally mounted relative to the annular member” (emphasis added), on the last line of the claim; however, these parameters are found to be confusing since it is not clear what exactly is meant by the terms “permanently” and “not pivotally”. Specifically, does “permanently” mean that the central member is always connected to the annular member, i.e. it is not modular/removable, or does it mean that the central member is not movable in reference to/at a fixed distance from the annular member; and does “not pivotally” mean the same as “permanently”, or does it mean the central member is not movable in reference to/at a fixed distance from the annular member, or can it move, but not flex, or do these terms mean something else completely different. Furthermore, the originally filed disclosure does not aid in clarifying these terms since it is completely silent regarding these terms; thus, one having ordinary skill in the art would not reasonably be apprised of the scope of the invention, thereby rendering the claim indefinite. Examiner’s Notes It is to be noted that in device/apparatus claims only the claimed structure of the final device bears patentable weight, and intended use/functional language is considered to the extent that it further defines the claimed structure of the final device (see MPEP 2114). Examiner cites particular columns and line numbers in the references as applied to the claims below for the convenience of the applicant(s). Although the specified citations are representative of the teachings in the art and are applied to the specific limitations within the individual claim, other passages and figures may apply as well. It is respectfully requested that, in preparing responses, the applicant(s) fully consider the references in entirety as potentially teaching all or part of the claimed invention, as well as the context of the passage as taught by the prior art or disclosed by the examiner. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 14-18 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Navia (US PG Pub. 2015/0094803), as disclosed in the IDS dated 05/02/2022. Regarding claims 14-18, Navia discloses an implantable device (10), illustrated in Figures 1A-1D, for repairing a cardiac valve having an annulus and two or more leaflets ([0083], Lines 1-4), the device (10) comprising an annular member (40) having a longitudinal axis (LA), the annular member (40) being dimensioned to attach to the annulus of the cardiac valve; a central member (60) having a longitudinal axis (CL), a distal portion (DP), a proximal portion (PP), a rigid or semi-rigid configuration and is configured with a curved/croissant shape to facilitate leaflet coaptation; and at least one connection member (62) fixedly supporting the central member (60) from the annular member (40); wherein the connection member (62) is configured such that the entirety of the distal portion of the central member (60) is permanently spaced apart from the annular member (40) and is not pivotally mounted relative to the annular member (40), and the connection member (62) is configured to maintain the longitudinal axis (CL) of the central member (60) at a predetermined angle (A), between 10 degrees and 60 degrees, relative to the longitudinal axis (LA) of the annular member (40) to induce the leaflets to contact toward the central member during systole, illustrated in Figures 1A-1D and modified figure 1D, below ([0084]; [0090]; [0091], Lines 1-2; [0097] & [0098]). PNG media_image1.png 343 543 media_image1.png Greyscale Claims 14, 15, 17, 18 and 20 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by He (US PG Pub. 2010/0262233). Regarding claim 14, He discloses an implantable device, illustrated in Figures 5A-5F, for repairing a cardiac valve having an annulus and two or more leaflets, illustrated in Figures 3A-4B ([0019] – [0022]), the device comprising an annular member (4.1) having a longitudinal axis (AL), the annular member being dimensioned to attach to the annulus (2.1) of the cardiac valve (2); a central member (4.2) having a longitudinal axis (CL), a distal portion, and a proximal portion; and at least one connection member (CM) fixedly supporting the central member (4.2) from the annular member (4.1); wherein the connection member (CM) is configured such that the entirety of the distal portion of the central member (4.2) is permanently spaced apart from the annular member (4.1) and is not pivotally mounted relative to the annular member (4.1), illustrated in Figures 5A-8, 12A-12C and modified figure 12A, below ([043] – [0045]; [0052] – [0055] & [0060]). PNG media_image2.png 358 285 media_image2.png Greyscale Regarding claim 15, He discloses the device according to claim 14, wherein the connection member (CM) is configured to maintain the longitudinal axis (CL) of the central member (4.2) at a predetermined angle (q) relative to the longitudinal axis (AL) of the annular member (4.1) to induce the leaflets (2.2/2.3) to contact toward the central member (4.2) during systole, illustrated in Figures 6A, 8, 12A-12C and modified figure 12A, above ([0053]; [0054]; [0056] & [0060]). Regarding claims 17 and 18, He discloses the device according to claim 14, wherein the central member (4.2) has a rigid/semi-rigid configuration and is configured with a curved/croissant shape to facilitate leaflet coaptation, illustrated in Figures 5A-5F ([0053]). Regarding claim 20, He discloses the device according to claim 14, wherein the entire central member (4.2) is dimensioned to be placed entirely between the leaflets (2.2/2.3), illustrated in Figures 6B and 8. Claims 14, 15 and 17-19 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Chau et al. (US PG Pub. 2011/0137397), hereinafter Chau. Regarding claim 14, Chau discloses an implantable device (3000), illustrated in Figures 71-74, for repairing a cardiac/mitral valve having an annulus (8) and two or more leaflets (12), illustrated in Figure 74 ([0158] & [0165]), the device (3000) comprising an annular member (3012&3014) having a longitudinal axis (AL), the annular member being dimensioned to attach to the annulus of the cardiac/mitral valve; a central member (3004) having a longitudinal axis (CL), a distal portion (DP), and a proximal portion (PP); and at least one connection member (3006) fixedly supporting the central member (3004) from the annular member (3012&314); wherein the connection member (3006) is configured such that the entirety of the distal portion (DP) of the central member is permanently spaced apart from the annular member (3012&314) and is not pivotally mounted relative to the annular member (3012&314), illustrated in Figures 71-74 and modified figure 71, below ([0159]; [0161] & [0163]). PNG media_image3.png 448 490 media_image3.png Greyscale Regarding claim 15, Chau discloses the device according to claim 14, wherein the connection member (3006) is configured to maintain the longitudinal axis (CL) of the central member (3004) at a predetermined angle relative to the longitudinal axis (AL) of the annular member (3012&314) to induce the leaflets (12) to contact toward the central member (3004) during systole, illustrated in Figures 71-74, 79 and modified figure 71, above. Regarding claims 17 and 18, Chau discloses the device according to claim 14, wherein the central member (3004) has a rigid or semi-rigid configuration and is configured with a curved/croissant shape to facilitate leaflet coaptation, illustrated in Figure 71 ([00159]). Regarding claim 19, Chau discloses the device according to claim 14, wherein the proximal portion (PP) of the central member (3004) is configured to be placed in an atrium (4) and the distal portion (DP) is configured to traverse the leaflets (12) into a ventricle (6), illustrated in Figure 71, 79 and modified 71, above. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim 16 is rejected under 35 U.S.C. 102(a)(1) as anticipated by or, in the alternative, under 35 U.S.C. 103 as obvious over He. Regarding claim 16, He discloses the device according to claim 15, wherein the predetermined angle is between 10 degrees and 60 degrees, illustrated in Figures 12A-12C and modified figure 12A, above. It is to be noted that the angles depicted in Figures 12A-12C visual represent angles between 10 degrees and 60 degrees; and though it is not specifically stated that the angles are between 10 degrees and 60 degrees, it would have been obvious, and well within the capability of one having ordinary skill in the art before the effective filing date of the invention to determine an appropriate predetermined angle, including between 10 degrees and 60 degrees, based on specific patient need/anatomy, and it has been held that where the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine skill in the art (see MPEP 2144.05). Claim 16 is rejected under 35 U.S.C. 103 as being unpatentable over Chau. Regarding claim 16, Chau discloses the device according to claim 15, and though it is not specifically disclosed that the predetermined angle is between 10 degrees and 60 degrees, this parameter is deemed to be a mere matter of normal design choice, not involving a novel, inventive step. It would have been obvious, and well within the capability of one having ordinary skill in the art before the effective filing date of the invention to determine an appropriate predetermined angle, including between 10 degrees and 60 degrees, based on specific patient need/anatomy, and it has been held that where the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine skill in the art (see MPEP 2144.05). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to DINAH BARIA whose telephone number is (571)270-1973. The examiner can normally be reached Monday - Friday 10am - 5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jerrah Edwards can be reached at 408-918-7557. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DINAH BARIA/Primary Examiner, Art Unit 3774 09/30/2026
Read full office action

Prosecution Timeline

May 02, 2022
Application Filed
Mar 26, 2025
Non-Final Rejection mailed — §102, §103, §112
Sep 26, 2025
Response Filed
Dec 23, 2025
Final Rejection mailed — §102, §103, §112
Feb 23, 2026
Response after Non-Final Action
Mar 17, 2026
Request for Continued Examination
Mar 27, 2026
Response after Non-Final Action
Oct 05, 2026
Non-Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12773477
SCAFFOLDING FOR IMPLANTABLE MEDICAL DEVICES AND METHODS OF USE THEREOF
5y 7m to grant Granted Oct 27, 2026
Patent 12773317
FASTENER AND TECHNIQUES THEREFOR
2y 10m to grant Granted Oct 27, 2026
Patent 12773482
DRUG ELUTING STENT AND METHOD OF USE OF THE SAME FOR ENABLING RESTORATION OF FUNCTIONAL ENDOTHELIAL CELL LAYERS
2y 9m to grant Granted Oct 27, 2026
Patent 12773474
VASCULAR REPAIR PATCH
2y 8m to grant Granted Oct 27, 2026
Patent 12752040
COMPRESSED BONE COMPOSITION AND METHODS OF USE THEREOF
3y 9m to grant Granted Oct 06, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
73%
Grant Probability
99%
With Interview (+28.2%)
2y 9m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 656 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month